LEXX   $2.11  -2.31% Market Closed

Lexaria Bioscience Corp
Total Cash 8.51M
totalCashPerShare 0.538
EBITDA -4.53M
Total Debt 142.59K
quickRatio 55.841
currentRatio 58.273
Total Revenue 411.02K
debtToEquity 1.463
Revenue/Share 0.039
ROA -0.38211
ROE -0.70655996
grossProfits
freeCashflow -3.21M
operatingCashflow -4.69M
earningsGrowth
revenueGrowth 0.081
grossMargins 0.98827004
ebitdaMargins 0.0
operatingMargins -20.74904
profitMargins 0.0
enterpriseValue 25.89M
forwardPE -5.615385
floatShares 13.23M
sharesOutstanding 17.45M
sharesShort 275.68K
sharesShortPriorMonth 317.45K
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.07%
heldPercentInstitutions 0.12%
Short Ratio help_outline 2.94%
shortPercentOfFloat 0.02%
impliedSharesOutstanding
bookValue 0.64
Price To Book help_outline 3.42
earningsQuarterlyGrowth
netIncomeToCommon -4.85M
trailingEps -0.43%
forwardEps -0.39%
enterpriseToEbitda -5.71
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.11 3Q 2024
institutionsCount 27
lastUpdated Nov. 7, 2024, 4:49 a.m.